🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. Viread 245 mg film-coated tablets, Viread 123 mg film-coated tablets, Viread 204 mg film-coated tablets, PTM Tenofovir DF, Viread 163 mg film-coated tablets, Viread 33 mg/g granules

    Gilead Sciences Pty Limited

    Hepatitis B Infection

    phase 3 small molecule active

    1 trial

  2. Virulizin®

    Aptose Biosciences

    Pancreatic Cancer

    phase 3 small molecule completed

    1 trial

  3. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 small molecule completed

    1 trial

  4. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 3 small molecule completed

    2 trials

  5. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 3 small molecule completed

    1 trial

  6. Vocabria 600 mg prolonged-release suspension for injection, REKAMBYS 900 mg prolonged-release suspension for injection

    ViiV Healthcare Pty Ltd

    HIV Infections

    phase 3 small molecule active

    1 trial

  7. Volanesorsen

    IONIS PHARMACEUTICALS INC

    Familial Chylomicronemia Syndrome

    phase 3 small molecule completed

    2 trials

  8. Volanesorsen

    IONIS PHARMACEUTICALS INC

    Hypertriglyceridemia

    phase 3 small molecule completed

    1 trial

  9. Volrustomig

    Arcus Biosciences

    Advanced Clear Cell Renal Cell Carcinoma

    phase 3 small molecule active

    1 trial

  10. Vonoprazan

    Phathom Pharmaceuticals

    Helicobacter Pylori Infection

    phase 3 small molecule completed

    1 trial

  11. Vortioxetine

    Takeda

    TBI

    phase 3 small molecule terminated

    1 trial

  12. Vortioxetine

    COGNITION THERAPEUTICS INC

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  13. Vortioxetine

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    9 trials

  14. Vortioxetine

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    5 trials

  15. Vortioxetine

    Takeda

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    3 trials

  16. Vortioxetine

    Takeda

    Treatment Outcome

    phase 3 small molecule completed

    1 trial

  17. Vortioxetine

    The University of Hong Kong

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial

  18. Vortioxetine 10 mg/day

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    2 trials

  19. Vortioxetine tablets

    Takeda

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  20. Vosoritide

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 3 small molecule active

    3 trials

  21. Voucher-Based Reinforcement Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-related Disorders

    phase 3 other completed

    1 trial

  22. Voxzogo 0.4 mg powder and solvent for solution for injection, Voxzogo 0.56 mg powder and solvent for solution for injection, Voxzogo 1.2 mg powder and solvent for solution for injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 3 small molecule active

    1 trial

  23. Voxzogo 1.2 mg powder and solvent for solution for injection, Voxzogo 0.4 mg powder and solvent for solution for injection, Voxzogo 0.56 mg powder and solvent for solution for injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Achondroplasia

    phase 3 small molecule active

    1 trial

  24. Voxzogo 1.2 mg powder and solvent for solution for injection, powder and solvent for solution for injection, Voxzogo 0.56 mg powder and solvent for solution for injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources